BCRB 2018

Stage I and II Hodgkin disease (very favorable and favorable categories)

RT

CH

CH+RT (IF, ≤ 40 Gy)

(EF, 40 Gy) (MOPP/ABVD)

10 y over. survival Complications (RR) -leukemia

80-90% 80-90% ≈90%

11.0 21.0

70.0 22.0

reduced reduced reduced reduced

-lymphoma -solid tumor

2.8

1.1

-cardiac

2.2-3.1

≈1.0

ESTRO 2018